ET
Ensho Therapeutics, Inc.
SEC filingBiotechnology · Woodcliff Lake, NJ
Amount raised$7.3Msold at filing
Total offering$15.6M$8.3M still open
Investors in the raise7count reported to the SEC
FiledOct 15, 2026first sale Oct 2, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Danielle FryExecutive Officer
Arash RassoulpourDirector
Carlos SolorzanoDirector
Eric PhamDirector
Gerhard HagnDirector
Neena Bitritto-GargDirector
Tariq KassumDirector
Executive officers, directors and promoters as listed on the Form D.